WASHINGTON: Gilead Science Inc's antiviral drug remdesivir was granted emergency use authorisation by the US Food and Drug Administration for COVID-19 on Friday , clearing the way for broader use of the drug in more hospitals around the United States.
With many countries reeling from the coronavirus pandemic, interest in Gilead’s drug has been high because there are currently no approved treatments or preventive vaccines for COVID-19.Data released this week from a trial by the National Institutes of Health in the United States showed that remdesivir reduced hospitalisation stays by 31 per cent compared to a placebo treatment, but did not significantly improve survival.
Remdesivir was previously available only for patients enrolled in clinical trials or for patients cleared to get the drug under expanded use and compassionate use programs. Gilead said the federal government will coordinate the donation and distribution of remdesivir to hospitals in cities hardest hit by COVID-19. Citing the drug's limited supply, the company said hospitals with intensive care units and other hospitals that the government deems most in need will receive priority.
Source: Healthcare Press (healthcarepress.net)
HOORAY HOORAY AGAIN!! And DOUBLE HOORAY!!
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: The Straits Times - 🏆 8. / 63 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »